InvestorsHub Logo
Followers 48
Posts 353
Boards Moderated 0
Alias Born 03/18/2009

Re: nuke661 post# 243680

Wednesday, 11/25/2015 12:56:16 PM

Wednesday, November 25, 2015 12:56:16 PM

Post# of 345700
I agree with your conclusion...

All along SK has been saying enrollment is on track, therefore assuming SK hasn't been BS'ing us on the enrollment, the movement of the expected 2nd look-in from expected end of 2015 (back in October of 2014) to mid 2016 (stated in this years ASM) should mean the trial is going much better than expected.



That's why my current favorite pick for final MOS is 15 months for Bavituximab combo vs. 10 months for Placebo combo.

Time will tell.

Regards
golfho
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News